The PE Ratio as of November 2024 (TTM) for ARCA biopharma, Inc. (ABIO) is -4.90

According to ARCA biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.90. This represents a change of -91.43% compared to the average of -57.15 of the last 4 quarters.

ARCA biopharma, Inc. (ABIO) Historical PE Ratio (quarterly & annually)

How has ABIO PE Ratio performed in the past?

The mean historical PE Ratio of ARCA biopharma, Inc. over the last ten years is -24.76. The current -4.90 PE Ratio has changed 1.88% with respect to the historical average. Over the past ten years (40 quarters), ABIO's PE Ratio was at its highest in in the March 2018 quarter at -7.47. The PE Ratio was at its lowest in in the December 2022 quarter at -128.07.

ARCA biopharma, Inc. (ABIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ARCA biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ARCA biopharma, Inc. (ABIO) Average PE Ratio

How has ABIO PE Ratio performed in the past?

The current PE Ratio of ARCA biopharma, Inc. (ABIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ARCA biopharma, Inc. (ABIO) PE Ratio vs. Peers

How is ABIO’s PE Ratio compared to its peers?

ARCA biopharma, Inc.’s PE Ratio is less than Aerovate Therapeutics, Inc. (-0.89), less than Adagene Inc. (-4.20), less than Acrivon Therapeutics, Inc. Common Stock (-4.11), less than Rezolute, Inc. (-4.04), less than AN2 Therapeutics, Inc. (-0.50), less than Indaptus Therapeutics, Inc. (-0.63), less than Tempest Therapeutics, Inc. (-0.67), less than Comera Life Sciences Holdings, Inc. (-0.00), greater than Forte Biosciences, Inc. (-5.73), less than ZIVO Bioscience, Inc. (-4.36), less than RenovoRx, Inc. (-3.02), less than Pasithea Therapeutics Corp. (-0.24), less than Quoin Pharmaceuticals, Ltd. (-0.44), less than Sio Gene Therapies Inc. (-4.77), less than Magenta Therapeutics, Inc. (-0.04), less than TRACON Pharmaceuticals, Inc. (0), less than CytomX Therapeutics, Inc. (0.02), less than Spero Therapeutics, Inc. (7.59), less than Neoleukin Therapeutics, Inc. (4.02), less than Instil Bio, Inc. (-0.98), less than NextCure, Inc. (-1.49), less than null (-0.60),

Build a custom stock screener for ARCA biopharma, Inc. (ABIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARCA biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ARCA biopharma, Inc. (ABIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ARCA biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.